Public Alert No. 030/2025 – Sale of Confirmed Substandard and Falsified ARTEMETRIN DS and CIPROFIT 500
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public about the sale of confirmed substandard and Falsified ARTEMETRIN DS and as CIPROFIT 500 in Nigeria. The ARTEMETRIN DS (Artemether/Lumefantrine) tablet (80mg/480mg) is labelled manufactured by A.C. DRUGS Ltd, Plot C5/C6 Old Airport Road, Emene- Enugu State, Nigeria. Also, the […]
Public Alert No. 029/2025 – Notice to Recall Embacef 125 Powder For Oral Suspension
The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a notification to Embassy Pharmaceutical and Chemicals Ltd, Lagos (Holder of Registration Certificate) and Laborate Pharmaceutical India, the manufacturer of Embacef 125 Powder for Oral Suspension, to recall its product following a received complaint reporting the caking of two bottles of the […]
Public Alert No. 028/2025 – Alert on Unregistered/Falsified Oxytocin Injection
The National Agency for Food and Drug Administration and Control (NAFDAC) hereby alerts the public about an unregistered Gold Vision Oxytocin injection 10IU with a fake NAFDAC Reg. No. A4-9566. The product is purportedly manufactured by Anhui Hongye Pharmaceutical Co., Ltd., Fengyang East Road, Bengbu, Anhui Province, China, and marketed by Gold Vision Medicals, No.4 […]
Public Alert No. 027/2025 – Alert on Confirmed Counterfeit Postinor2 (Levonorgestrel 0.75mg) in Nigeria
The National Agency for Food and Drug Administration and Control (NAFDAC) hereby notifies the public of falsified Type 1 and 2 batches of POSTINOR 2 (Levonorgestrel 0.75mg) product in circulation. A report was received from the Society of Family Health (SFH), the MAH, which confirmed that their company did not import that product batch. The […]
NAFDAC – PCN Retains WHO Maturity Level 3 (ML3) Status for Regulation of Medicines and Vaccines
The National Agency for Food and Drug Administration and Control (NAFDAC) is pleased to announce that the World Health Organization (WHO) has officially reaffirmed Nigeria’s achievement of Maturity Level 3 (ML3) for the regulation of medicines and vaccines, effective 30th June 2025. This recognition followed WHO’s formal re-benchmarking exercise conducted in Abuja and Lagos from […]
Strengthening Food Safety Partnerships: NAFDAC and UN World Food Programme Sign MoU
Remarks by Prof. Adeyeye C M, Director General NAFDAC Signing of Memorandum of Understanding (MoU) Between NAFDAC and the United Nations World Food Programme NAFDAC Headquarters, Abuja 11th August, 2025. PROTOCOLS Kushro JAWED, Head of Supply ChainMohamed MOAWAD, Head of Food Safety and QualityOlabisi OGUNGBEMI, Head of Governmental PartnershipsOwen OSAIGBOVO, Food Safety and Quality AssistantDistinguished NAFDAC […]
Public Alert No. 026/2025 – Alert on the Circulation of Counterfeit Cowbell “Our Milk” Milk in Nigeria
The National Agency for Food and Drugs Administration and Control (NAFDAC) is informing the public of the presence of counterfeit Cowbell “Our Milk” 12g sachet milk circulating in Nigeria. Promasidor Nigeria Ltd, which is the Marketing Authorization Holder and manufacturer of Cowbell “Our Milk” informed the agency about the existence of product bearing a close […]
Public Alert No. 025/2025 – Alert on the Unauthorized Auction and Circulation of Expired Insecticide (LARA FORCE LAMBDA 1L)
The National Agency for Food and Drugs Administration and Control (NAFDAC) is informing the public of the Circulation of Expired Insecticide (Lara Force Lambda Cyhalothrin 2.5% 1 Litre (Batch Xzh2020006)). 5000 cartons of the expired product were discovered to have been unlawfully auctioned to various third-party buyers, and investigations revealed that they originally expired on […]
Public Alert No. 024/2025 – Recall of Amoxivue (Amoxicillin) 500mg Capsules due to significantly low Active Pharmaceutical Ingredient (API) content
The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting the public about the recall of Amoxivue (Amoxicillin) 500mg, with NAFDAC NO: A4-100178 and Batch NO: 322584, manufactured by Sparsh Bio-Tech Pvt, Ltd. Note: Sparsh Bio-Tech has declared no relationship with the MAH- MedVue Pharmaceutical Ltd. A batch of Amoxivue capsules (Amoxicillin […]
NAFDAC Hosts African ML3 National Regulatory Agencies Meeting in Abuja, Nigeria
The History of Who We Are and Where We Are Going The Abuja ML3 NRAs Meeting: The Director-General of NAFDAC, Prof. Mojisola Adeyeye, welcomed Heads of seven other WHO Maturity Level 3 agencies to Abuja on Monday, July 7, 2025. In her Opening Remarks, she went down memory lane on the history of the WHO […]
